Business
How Moderna went from coronavirus sequence to a phase-1-ready vaccine candidate in 42 Days – Motley Fool Australia
The biotech got a little help from Amazon’s AWS.
Moderna(NASDAQ:MRNA), one of the leaders in the race to develop a coronavirus vaccine, was able to take the initial coronavirus sequence and get a vaccine candidate, mRNA-1273, ready for a phase 1 clinical trial in just 42 days.
The biotech’s use of Amazon Web Services (AWS), the cloud-based computing service run by Amazon (NASDAQ:AMZN), enabled this quick development. Moderna runs its Drug Design Studio on AWS, which allows it to design its mRNA drug candidates quickly.
The potential drugs ar…
-
Noosa News21 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Noosa News23 hours agoParkyn this, Parkyn that | Noosa Today
-
Noosa News23 hours agoR Tee in the running to be top dog
-
Noosa News20 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway